Le Lézard
Classified in: Science and technology
Subjects: CCA, FVT

Qualys to Report Fourth Quarter and Full Year 2019 Financial Results on February 12


FOSTER CITY, Calif., Jan. 13, 2020 /PRNewswire/ -- Qualys, Inc. (NASDAQ: QLYS), a pioneer and leading provider of cloud-based IT, security and compliance solutions, today announced that the company will report its financial results for the fourth quarter and full year 2019 after the market closes on Wednesday, February 12, 2020.

Qualys will host a conference call and live webcast to discuss its fourth quarter and full year 2019 financial results at 4:45 p.m. Eastern Time (1:45 p.m. Pacific Time) on Wednesday, February 12, 2020. To access the conference call, dial (877) 881-2609 in the U.S. or (970) 315-0463 for international participants with conference ID #3389315. A live webcast of the earnings conference call, investor presentation, prepared remarks, and supplemental historical financial spreadsheet can be accessed at https://investor.qualys.com/events-presentations. A replay of the conference call will be available through the same webcast link following the end of the call.

About Qualys, Inc.
Qualys, Inc. (NASDAQ: QLYS) is a pioneer and leading provider of cloud-based IT, security and compliance solutions with over 12,200 customers and active users in more than 130 countries, including a majority of each of the Forbes Global 100 and Fortune 100. Qualys helps organizations streamline and consolidate their IT, security and compliance solutions in a single platform and build security into digital transformation initiatives for greater agility, better business outcomes and substantial cost savings. The Qualys Cloud Platform and its integrated Cloud Apps deliver businesses critical security intelligence continuously, enabling them to automate the full spectrum of auditing, compliance and protection for IT systems and web applications across on premises, endpoints, cloud, containers, and mobile environments. Founded in 1999 as one of the first SaaS security companies, Qualys has established strategic partnerships with leading cloud providers like Amazon Web Services, Microsoft Azure and the Google Cloud Platform, and managed service providers and consulting organizations including Accenture, BT, Cognizant Technology Solutions, Deutsche Telekom, DXC Technology, Fujitsu, HCL Technologies, IBM, Infosys, NTT, Optiv, SecureWorks, Tata Communications, Verizon and Wipro. The company is also a founding member of the Cloud Security Alliance. For more information, please visit www.qualys.com.

Qualys and the Qualys logo are proprietary trademarks of Qualys, Inc. All other products or names may be trademarks of their respective companies.

Investor Contact
Vinayak Rao
Vice President, Corporate Development and Investor Relations
(650) 801-6210
[email protected]

SOURCE Qualys, Inc.


These press releases may also interest you

at 08:30
Munich Re Life US and Clareto today announced a new digital solution, Automated EHR Summarizer, which provides an intelligent and intuitive synopsis of electronic health record (EHR) data in two formats: an easy-to-use human-readable html report and...

at 08:30
Agilysys, Inc. , a leading global provider of hospitality software solutions and services, today debuted revenue optimization enhancements leveraging AI technology incorporated in Agilysys Spa. These new revenue optimization capabilities, powered by...

at 08:30
RAD AI, the leader in AI-powered audience-first marketing and communications solutions, today unveiled its new strategy to rapidly reform the industry's landscape: Artificial Intelligence Buyouts (AIBOs). This strategic endeavor is designed to...

at 08:30
Outpost (www.outpost.us), a leading network of managed semi-truck parking facilities, today announced that it has raised $12.5 million in Series A funding, led by GreenPoint Partners with support from Speedwagon Capital Partners, to accelerate...

at 08:30
Alto Neuroscience, Inc. ("Alto") today announced positive results from its healthy volunteer Phase 1 study of ALTO-101, a novel PDE4 inhibitor in development for cognitive impairment associated with schizophrenia (CIAS). Results from the study...

at 08:30
Hera Biotech is pleased to report the interim results for its proof-of-concept multi-center clinical trial of the MetriDxtm endometriosis diagnostic test. Per protocol data from the first 38 patients who have been enrolled in the 60 patient study...



News published on and distributed by: